Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia

A. van der Veer, V.H.J. van der Velden, M.E. Willemse, P.G. Hoogeveen, E.F. Petricoin, H.B. Beverloo, G. Escherich, M.A. Horstmann, F. Pieters, M.L. van den Boer*

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Article numbere181
JournalBlood Cancer Journal
Publication statusPublished - 2014

Cite this